Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000481019 | SCV000565997 | likely pathogenic | not provided | 2022-06-17 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30124108, 28720891, 31130284, 28454995) |
Baylor Genetics | RCV000723283 | SCV001522292 | pathogenic | Multiple sulfatase deficiency | 2020-04-14 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV000723283 | SCV001591305 | pathogenic | Multiple sulfatase deficiency | 2023-10-28 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 262 of the SUMF1 protein (p.Gln262Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with multiple sulfatase deficiency (PMID: 28454995, 30124108). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 418724). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SUMF1 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000723283 | SCV002027601 | pathogenic | Multiple sulfatase deficiency | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000723283 | SCV005038888 | likely pathogenic | Multiple sulfatase deficiency | 2025-01-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000624193 | SCV000742689 | uncertain significance | Inborn genetic diseases | 2017-08-15 | flagged submission | clinical testing | Lines of evidence used in support of classification: NEGATIVE - No Relevant Alterations Detected (Step 2) |
Biochemical Molecular Genetic Laboratory, |
RCV000723283 | SCV000854672 | pathogenic | Multiple sulfatase deficiency | 2018-05-03 | no assertion criteria provided | clinical testing |